Zdrojowy-Wełna Aleksandra, Bednarek-Tupikowska Grazyna
Department of Endocrinology, Diabetology and Isotope Therapy, Medical University Wroclaw, Poland.
Neuro Endocrinol Lett. 2014;35(5):355-8.
Adrenal pheochromocytomas are rare neuroendocrine tumours, however their prevalence is probably underestimated - in some series 50% were diagnosed at autopsy. The clinical presentation varies among patients, that is why diagnosis might be difficult to establish. Pheochromocytoma may coexist with paraganglioma and when paraganglioma is diagnosed, the patient should be screened for pheochromocytoma too, especially in people with hypertension. We present a case of woman with pheochromocytoma, but diagnosed after incidence of stroke, who had also paraganglioma in the past. Additionally, a teratoma was diagnosed simultaneously.
49-year old woman with hypertension was referred to the Department of Endocrinology, Diabetology and Isotope Therapy in Wrocław with suspected pheochromocytoma. She was operated twice because of paraganglioma of the right and left carotid artery, second operation was complicated with stroke. After administration of anticoagulants a bleeding from gastrointestinal tract occurred. During diagnostic process CT of the abdomen showed tumour in the right adrenal gland and a tumour in pelvis. Significantly elevated catecholamines and their metabolites in blood and urine confirmed the diagnosis of pheochromocytoma. Both tumours were removed surgically, the second was teratoma maturum. Genetic screening for hereditary pheochromocytoma was proceeded. A mutation in SDHD gene was revealed in patient's DNA and subsequently in blood samples of her sister and daughter.
Occurrence of paraganglioma with hypertension suggest need of screening for pheochromocytoma-paraganglioma syndrome, especially in case of paragangliomas in family history. Early treatment is crucial to avoid life-threatening cardiovascular complications. The association between pheochromocytoma and teratoma is unclear.
肾上腺嗜铬细胞瘤是罕见的神经内分泌肿瘤,但其患病率可能被低估了——在一些系列研究中,50%的病例是在尸检时被诊断出来的。患者的临床表现各不相同,这就是为什么诊断可能难以确立。嗜铬细胞瘤可能与副神经节瘤共存,当诊断出副神经节瘤时,患者也应接受嗜铬细胞瘤筛查,尤其是高血压患者。我们报告一例患有嗜铬细胞瘤的女性病例,该病例在中风后才被诊断出来,她过去也曾患过副神经节瘤。此外,同时诊断出一个畸胎瘤。
一名49岁患有高血压的女性因疑似嗜铬细胞瘤被转诊至弗罗茨瓦夫的内分泌学、糖尿病学和同位素治疗科。她因左右颈动脉副神经节瘤接受了两次手术,第二次手术并发中风。在使用抗凝剂后,发生了胃肠道出血。在诊断过程中,腹部CT显示右肾上腺有一个肿瘤,盆腔也有一个肿瘤。血液和尿液中儿茶酚胺及其代谢产物显著升高,证实了嗜铬细胞瘤的诊断。两个肿瘤均通过手术切除,第二个是成熟畸胎瘤。对遗传性嗜铬细胞瘤进行了基因筛查。在患者的DNA中发现了SDHD基因突变,随后在她姐姐和女儿的血液样本中也发现了该突变。
副神经节瘤合并高血压提示需要筛查嗜铬细胞瘤-副神经节瘤综合征,尤其是有家族性副神经节瘤病史的情况。早期治疗对于避免危及生命的心血管并发症至关重要。嗜铬细胞瘤与畸胎瘤之间的关联尚不清楚。